Circumstance
|
Recommended Action
|
Clinical Reasoning
|
Prescription medications (including for Parkinson’s)*
|
Do not make any changes to a patient’s medication unless they increase photosensitivity. Discuss with your prescribing healthcare practitioner first.
If taking blood thinners, seek medical clearance before using a SYMBYX helmet or applying light therapy to the head.
If taking blood thinners because of a history of stroke, then do not use the SYMBYX helmet or apply any form of light therapy to the head.
|
SYMBYX lasers are designed to complement all pre-existing therapies.
Insufficient supporting evidence for applying light therapy to the head if taking blood thinners, even though no negative episodes have been documented.
|
Patients suffering from extreme sensitivity to light (incl vestibular migraine; epilepsy)
|
Do not treat with SYMBYX products.
|
Risk of invoking a deleterious episode.
|
Pregnancy
|
Do not treat with SYMBYX products.
|
Insufficient supporting evidence, even-though no negative episodes have been documented.
|
Heart conditions*
|
Treat with caution**.
|
Light therapy might temporarily increase autonomic symptoms, including heart rate. If this happens, patients should immediately contact Clinical Support at clinicalsupport@symbyxbiome.com. It is very important to proceed with caution and ensure clinical supervision.
|
Deep Brain Stimulation (DBS)
|
Do not treat with SYMBYX Neuro helmet.
You may treat with all other SYMBYX products (PDCare, PhysioCare, DermaCare, DuoCare and Pro Series Lasers), according to SYMBYX protocols.
|
Insufficient supporting evidence, even-though no negative episodes have been documented.
|
History of acute psychiatric episodes, severe hypermobility (incl Ehlos Danos); acute polyarthritic disorders*
|
Treat under the supervision of a clinician.
If you have a history of psychiatric episode, seek medical clearance before treating with the SYMBYX Neuro helmet.
|
Insufficient supporting evidence, even-though no negative episodes have been documented.
Hypermobility and polyarthritic conditions are often accompanied by dysautonomia.
Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.
|
Rheumatoid Arthritis*
|
Treat with caution.
|
Insufficient supporting evidence, even-though no negative episodes have been documented. Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.
|
Stroke
|
Do not treat with the SYMBYX Neuro helmet.
You may treat with all other SYMBYX products (PDCare, PhysioCare, DermaCare, DuoCare and Pro Series Lasers), according to SYMBYX protocols.
|
Light therapy improves circulation, which may cause further functional or structural deficit, even though no negative episodes have been documented.
|
Tumour site (active primary or secondary)
|
Never treat over an active tumour site.
Seek medical clearance before commencing laser therapy.
|
Insufficient supporting evidence, even-though no negative episodes have been documented.
|
Acute head trauma and concussion
|
Seek medical clearance before commencing laser therapy.
|
Internal bleeding may develop over the following days and weeks after a head trauma and may be asymptomatic. As light therapy improves circulation, this can cause further functional or structural deficit, even though no negative episodes have been documented.
|
Migraines*
|
Treat with caution
Do not apply light to the head during an acute migraine episode.
|
Light therapy improves circulation, which may cause further functional or structural deficit during a migraine episode, even though no negative episodes have been documented.
|
Acute, severe head pain
|
Seek medical clearance or emergency services before commencing laser therapy.
|
A formal medical diagnosis and clearance is needed before any treatment should be administered.
|